Sustained efficacy of dapagliflozin when added to metformin in type 2 diabetes inadequately controlled by metformin monotherapy

被引：0
|
作者：
Bailey, C. J. [1 ]
Gross, J. L. [2 ]
Yadav, M. [3 ]
Iqbal, N. [4 ]
Mansfield, T. A. [4 ]
List, J. F. [4 ]
机构：
[1] Aston Univ, Birmingham B4 7ET, W Midlands, England
[2] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil
[3] Bristol Myers Squibb, Bombay, Maharashtra, India
[4] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
DIABETOLOGIA | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
146
引用
下载
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [21] THE COST-EFFECTIVENESS EVALUATION OF CANAGLIFLOZIN VERSUS DAPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED ON METFORMIN MONOTHERAPY IN SPAIN
    Nielsen, A. T.
    Pitcher, A.
    Lovato, E.
    Schubert, A.
    Hemels, M.
    Neslusan, C.
    Gonzalez, B.
    VALUE IN HEALTH, 2015, 18 (03) : A61 - A61
  • [22] Efficacy and safety of exenatide in patients of Asian descent with type 2 diabetes inadequately controlled with metformin or metformin and a sulphonylurea
    Gao, Yan
    Yoon, Kun Ho
    Chuang, Lee-Ming
    Mohan, Viswanathan
    Ning, Guang
    Shah, Sanjiv
    Jang, Hak Chul
    Wu, Ta-Jen
    Johns, Don
    Northrup, Justin
    Brodows, Robert
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 83 (01) : 69 - 76
  • [23] Vildagliptin efficacy in combination with metformin among Jordanian patients with type 2 diabetes mellitus inadequately controlled with metformin
    Al Omari, Mousa
    Khader, Yousef
    Dauod, Ali Shakir
    Yonis, Othman Ahmed Beni
    Khassawneh, Adi Harbi Mohammad
    JOURNAL OF DRUG ASSESSMENT, 2016, 5 (01) : 29 - 33
  • [24] Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia
    Ji, Linong
    Liu, Yanmei
    Miao, Heng
    Xie, Yongli
    Yang, Ming
    Wang, Wei
    Mu, Yuting
    Yan, Ping
    Pan, Sharon
    Lauring, Brett
    Liu, Shu
    Huyck, Susan
    Qiu, Yanping
    Terra, Steven G.
    DIABETES OBESITY & METABOLISM, 2019, 21 (06): : 1474 - 1482
  • [25] Dapagliflozin versus saxagliptin as add-on therapy in patients with type 2 diabetes inadequately controlled with metformin
    Rosenstock, Julio
    Mathieu, Chantal
    Chen, Hungta
    Garcia-Sanchez, Ricardo
    Saraiva, Gabriela Luporini
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2018, 62 (04): : 424 - 430
  • [26] EFFICACY AND SAFETY OF ANAGLIPTIN COMPARED WITH SITAGLIPTIN AS AN ADD-ON FOR PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED WITH METFORMIN MONOTHERAPY
    Jin, S. -M.
    Park, S. W.
    Yoon, K. -H.
    Lee, M. -K.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S135 - S136
  • [27] Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes inadequately controlled with metformin monotherapy: VERTIS-Asia
    Yang, M.
    Ji, L.
    Liu, Y.
    Miao, H.
    Xie, Y.
    Wang, W.
    Mu, Y.
    Yan, P.
    Pan, S.
    Lauring, B.
    Liu, S.
    Huyck, S.
    Wang, D.
    Terra, S. G.
    DIABETOLOGIA, 2018, 61 : S307 - S308
  • [28] Vildagliptin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy: efficacy and tolerance at 52 weeks
    Halimi, S.
    Dejager, S.
    Arnou, R.
    Delamare, G.
    Ferrannini, E.
    DIABETES & METABOLISM, 2009, 35 : A8 - A8
  • [29] Efficacy and safety of dapagliflozin plus saxagliptin vs monotherapy as added to metformin in patients with type 2 diabetes A meta-analysis
    Zhuang, Yan
    Song, Jin
    Ying, Miaofa
    Li, Mingxing
    MEDICINE, 2020, 99 (30) : E21409
  • [30] Efficacy and Safety of Antihyperglycemic Agents Added to Metformin Monotherapy in Patients with Type 2 Diabetes
    Mearns, Elizabeth S.
    Sobieraj, Diana M.
    White, C. Michael
    Saulsberry, Whitney J.
    Doleh, Yunes
    Zaccaro, Eric
    Coleman, Craig I.
    DIABETES, 2015, 64 : A658 - A658
12345